Tailoring a fun, tech-assisted mental health program for teens and young adults with blood cancers
Official title: Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant
Funded at University of Chicago · NIH-11362023 · Data updated 2026-11-12
A planning grant to adapt a technology-based cognitive behavioral therapy program to meet the unique needs of adolescents and young adults with hematologic cancers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | June 1, 2025 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $332,527 |
| NIH project number | 5R34CA297498-02 |
| Project ID | NIH-11362023 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adolescents and young adults diagnosed with hematologic malignancies who experience or are at risk of depression or psychosocial distress.
✕Less likely to help
AYAs without hematologic malignancies or those not experiencing mental health concerns may derive little direct benefit.
What this research studies
This grant focuses on adapting an engaging digital CBT platform for AYAs with hematologic malignancies to address depression and psychosocial needs. AYA survivors, clinicians, and care teams will collaborate to tailor content, usability, and engagement features. The project will gather input from an advisory panel and plan the next study phase to test the customized program in real-world settings. The aim is to reduce mental health disparities and improve quality of life for this population.
Why it matters
Potential benefit: If successful, AYAs with blood cancers could receive a more engaging and accessible digital mental health tool tailored to their cancer journey.
How similar studies have gone: Preliminary testing of a similar tech-assisted CBT for AYAs showed promise, but this project tailors the approach specifically for HM patients and plans further development.
Where this research is happening
-
University of Chicago
Chicago, United States Active
Researchers
- Principal investigator: Duvall, Adam Spence — University of Chicago
- Study coordinator: Duvall, Adam Spence
Related research
Other NIH-funded projects on the same topics.
-
Engineering CD19 mimotopes to boost and broaden CD19-CAR T cell therapy
A patient-focused look at improving existing CD19-CAR T cell therapy so more people with blood cancers might benefit.
-
Disrupting BM niches and boostingCAR-T therapy in blood cancers
A program at Washington University is developing better ways to collect stem cells for transplantation, reduce graft-versus-host disease, and improve CAR-T cell therapies for blood cancers.
-
Time-restricted eating to help fatigue in blood cancer survivors
A 12-week program tests whether eating within a daytime 10-hour window can reduce fatigue in people who have survived blood cancers.
-
Optimizing Blood Stem Cell Transplants for Blood C cancers and related diseases
This grant supports improving how stem cell transplants are collected and given, with the goal of better outcomes and fewer side effects for people with blood cancers and some autoimmune or inherited conditions.
-
Off-the-Shelf Immune Cells to Fight Childhood Blood Cancers
A US study from Minnesota is exploring ready-to-use immune cells to treat kids with leukemia that may not respond to standard therapies.
-
Improving care for leukemia and other blood cancers
This program is developing better ways to diagnose, predict outcomes, and treat leukemia and related blood cancers for children and adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.